Nissan (OTC:NSANY) is set to announce a leadership shake-up on March 12 as part of its accelerated turnaround plan, sources revealed. Despite speculation about his removal, CEO Makoto Uchida is expected to remain in his position for now.
The restructuring follows Nissan’s failed merger talks with Honda (NYSE:HMC), which aimed to create a $60 billion automotive giant. The negotiations collapsed after Honda proposed making Nissan a subsidiary, sources said.
Struggling with declining performance, Nissan has reported two consecutive quarters of weak results and recently cut its annual forecast for the third time. The automaker plans to shut down three plants and streamline management to improve profitability.
Nissan’s board continues to assess the turnaround strategy and leadership team. While there have been discussions about replacing Uchida, insiders indicate that if he steps down, an interim CEO might be appointed instead of a permanent successor.
Shares of Nissan surged 3.7% in Tokyo, outperforming the Nikkei’s 0.4% rise. Analysts suggest that a leadership change alone may not be a quick fix for Nissan’s ongoing challenges.
Uchida, who has been CEO since 2019, has emphasized the urgency of revitalizing Nissan before considering his departure. However, no clear successor has emerged.
The automaker’s struggles in key markets, including the U.S. and China, underline the urgency of the upcoming changes. Nissan’s ability to execute its turnaround strategy will be closely watched as it navigates financial and operational challenges.
A Nissan spokesperson declined to comment on the leadership transition.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



